Company Data

Curis Inc.

Ticker
CRIS
Current Price
$3.1
Market Cap
$26.2M
Price Target
Refer to Report
Volume
19.3K
52wk Range
$2.86 - $17.49
Advanced Market Data

Overview

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy